West Pharmaceutical Services | WST - Interest Expense On Debt


West Pharmaceutical Services reported $1.9M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Align Technology USD 6.93M 9.11M Mar/2026
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Cerus USD 2.33M 96K Jun/2024
Charles River Laboratories USD 30.34M 3.6M Jun/2026
Cooper Companies USD 21.5M 600K Jun/2026
Dentsply International USD 22M 2M Jun/2026
Haemonetics USD 5.08M 2.32M Mar/2026
ICU Medical USD 18.53M 2.11M Mar/2026
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.99M 529K Jun/2026
IQVIA Holdings USD 197M 5M Jun/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 186M 10M Jun/2026
Merit Medical Systems USD 12.12M 5.59M Jun/2026
Neogen USD 13.9M 356K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Quidel USD 5.63B 5.58B Mar/2026
Repligen USD 5.66M 85K Jun/2026
Rockwell Medical USD 232K 199K Jun/2024
Solventum Corp USD 14.24B 146M Jun/2026
STAAR Surgical USD 800K 799K Sep/2025
Terumo JPY 1.48B 51M Jun/2026
West Pharmaceutical Services USD 1.9M 1.7M Mar/2026